ANIXA BIOSCIENCES, INC. Proceeds from License Fees Received
ANIXA BIOSCIENCES, INC. (ANIX) reported Proceeds from License Fees Received of $0 for the 3-month period ending 2013-04-30, per its 10-Q/A filed 2013-06-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLicenseFeesReceived · last filed 2013-06-19
- ANIXA BIOSCIENCES, INC. proceeds from license fees received for the quarter ending 2013-04-30 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. proceeds from license fees received for the quarter ending 2012-04-30 was $247.00K.
- ANIXA BIOSCIENCES, INC. proceeds from license fees received for the quarter ending 2011-10-31 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. proceeds from license fees received for the quarter ending 2010-10-31 was $300.00K.
- ANIXA BIOSCIENCES, INC. proceeds from license fees received for fiscal 2011 was $2.40M, a 300.00% increase from fiscal 2010.
- ANIXA BIOSCIENCES, INC. proceeds from license fees received for fiscal 2010 was $600.00K.
| Period end | Proceeds from License Fees Received 3 month | Proceeds from License Fees Received 6 month | Proceeds from License Fees Received 9 month | Proceeds from License Fees Received 12 month |
|---|---|---|---|---|
| 2013-04-30 | $0.00 10-Q/A · filed 2013-06-19 | $0.00 10-Q/A · filed 2013-06-19 | ||
| 2012-04-30 | $247.00K 10-Q/A · filed 2013-06-19 | $693.00K 10-Q/A · filed 2013-06-19 | ||
| 2011-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $2.40M 10-K · filed 2013-01-29 | ||
| 2011-07-31 | $2.40M 10-Q · filed 2012-09-14 | |||
| 2010-10-31 | $300.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $600.00K 10-K · filed 2012-01-30 | ||
| 2010-07-31 | $300.00K 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |